SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CELEGHINI, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.391
AS - Asia 2.721
EU - Europa 1.648
SA - Sud America 519
AF - Africa 49
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 11.338
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.277
SG - Singapore 1.109
CN - Cina 780
BR - Brasile 448
IT - Italia 310
DE - Germania 279
UA - Ucraina 275
TR - Turchia 247
PL - Polonia 228
HK - Hong Kong 217
GB - Regno Unito 180
VN - Vietnam 169
FI - Finlandia 91
RU - Federazione Russa 78
SE - Svezia 69
CA - Canada 54
MX - Messico 46
ID - Indonesia 43
IN - India 37
AR - Argentina 29
ES - Italia 28
NL - Olanda 28
ZA - Sudafrica 28
FR - Francia 25
EC - Ecuador 17
BD - Bangladesh 14
BE - Belgio 14
JP - Giappone 13
PK - Pakistan 12
AT - Austria 10
IR - Iran 9
CO - Colombia 8
IQ - Iraq 8
LT - Lituania 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 6
IL - Israele 6
MA - Marocco 6
NP - Nepal 6
CZ - Repubblica Ceca 5
JO - Giordania 5
KZ - Kazakistan 5
UZ - Uzbekistan 5
AU - Australia 4
EG - Egitto 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
CL - Cile 3
DZ - Algeria 3
HN - Honduras 3
IE - Irlanda 3
JM - Giamaica 3
KE - Kenya 3
MY - Malesia 3
PE - Perù 3
PY - Paraguay 3
RO - Romania 3
TH - Thailandia 3
VE - Venezuela 3
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
GE - Georgia 2
KR - Corea 2
MD - Moldavia 2
OM - Oman 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
KG - Kirghizistan 1
LB - Libano 1
ML - Mali 1
MW - Malawi 1
PA - Panama 1
PF - Polinesia Francese 1
QA - Qatar 1
SN - Senegal 1
TJ - Tagikistan 1
Totale 11.338
Salva come PNG Salva come JPEG
Città #
Woodbridge 820
Fairfield 712
Ashburn 629
Singapore 594
Houston 380
Jacksonville 332
Seattle 318
Chandler 306
Cambridge 305
Beijing 272
Santa Clara 251
Wilmington 246
Ann Arbor 245
Warsaw 226
Hong Kong 217
Izmir 137
Ferrara 129
Dallas 100
Los Angeles 100
Nanjing 96
New York 81
Princeton 76
Boardman 64
Munich 61
Milan 48
Ho Chi Minh City 47
Dearborn 41
San Diego 40
The Dalles 35
Jakarta 34
Nanchang 34
Shanghai 34
São Paulo 34
Columbus 33
Hanoi 33
Mexico City 31
Buffalo 25
Shenyang 24
Bremen 23
Tianjin 23
Changsha 22
London 22
Johannesburg 21
Turku 21
Jinan 20
Denver 19
Montreal 19
Mountain View 19
Jiaxing 17
Chennai 16
Chicago 16
Frankfurt am Main 16
Manchester 16
Moscow 16
Orem 16
Falls Church 15
Hebei 15
Brooklyn 14
San Jose 14
Brussels 13
Dong Ket 13
Kunming 13
San Mateo 13
Stockholm 13
Zhengzhou 13
Boston 12
Council Bluffs 12
Leawood 12
Poplar 12
Rio de Janeiro 12
Toronto 12
Bologna 11
Hefei 11
San Francisco 11
Aprilia 10
Falkenstein 10
Helsinki 10
Redwood City 10
Washington 10
Norwalk 9
Phoenix 9
Tappahannock 9
Tokyo 9
Ankara 8
Auburn Hills 8
Brasília 8
Da Nang 8
Campinas 7
Changchun 7
Curitiba 7
Guangzhou 7
Haikou 7
Hải Dương 7
Morciano Di Romagna 7
Ningbo 7
Nuremberg 7
Orange 7
Ottawa 7
Quito 7
Atlanta 6
Totale 7.961
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 262
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 254
Neuronal dysfunction associated with cholesterol deregulation 247
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 236
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometry 216
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 215
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 192
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies 189
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 188
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 187
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 184
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 183
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells 176
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 172
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 169
Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesis 167
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells 166
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 150
Levels of circulating TNF-related apoptosis-inducing ligand in celiac disease 148
Total extract of Beta vulgaris var. cicla seeds versus its purified phenolic components: antioxidant activities and antiproliferative effects against colon cancer cells 148
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 144
HIV-1 Tat protein suppresses the nerve growth factor (NGF)-mediated differentiation of PC12 rat pheochromocytoma cell line 142
All-Trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients 133
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 131
In situ polymerase chain reaction technique revealed by flow cytometry as a tool for gene detection 129
HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand 128
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib 127
Repositioning of Tak-475 in mevalonate kinase disease: Translating theory into practice 126
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction 125
Activation of the nitric oxide synthase pathway represents a key component of the TNF-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity on hematological malignancies. 124
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. 123
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate 122
Subcellular localization of the regulatory HIV-1 Tat protein produced endogenously by or added exogenously to PC12 rat pheochromocytoma and human Jurkat T lymphoid cells 121
Molecular and imaging prodromal markers of dopamine neuron degeneration in animal models of Parkinson’s disease: pathophysiology and clinical perspectives 115
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 112
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL) 107
Pre-eclampsia affects procalcitonin production in placental tissue 106
null 105
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 105
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 103
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 102
In vivo and in vitro modulatory effect of human immunodeficiency virus type (HIV-1) Tat protein on protein kinase C activity. 102
Differential effects of stromal derived factor-1 alpha (SDF-1alpha) on early and late stages of human megakaryocytic development. 99
null 98
null 97
Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4+ T cells. 95
null 94
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 94
Ceramides as the molecular link between impaired lipid metabolism, saturated fatty acid intake and insulin resistance: are all saturated fatty acids to be blamed for ceramide-mediated lipotoxicity? 92
null 92
null 90
null 90
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis. 90
Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells 90
null 89
null 89
null 89
null 89
null 88
null 88
null 88
null 86
null 86
null 86
null 86
null 86
null 85
null 83
null 83
null 82
null 81
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 81
null 81
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development 79
Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitus 78
null 78
Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. 77
null 76
null 76
null 76
null 76
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro 74
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes 71
Purinergic Signaling in Controlling Macrophage and T Cell Functions During Atherosclerosis Development 71
MitoQ is able to modulate apoptosis and inflammation 69
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 67
null 66
null 65
Potential role of circulating microRNAs as early markers of preeclampsia 64
The induction of megakaryocyte differentiation is accompanied by selective Ser133 phosphorylation of the transcription factor CREB in both HEL cell line and primary CD34+ cells 61
Soluble TRAIL is present at high concentrations in seminal plasma and promotes spermatozoa survival 60
Tumor necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 58
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo 58
Impaired survival of bone marrow GPIIb/IIIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia 52
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway 50
null 49
Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease 47
null 45
NF-κB pathways in hematological malignancie 45
null 44
Totale 10.960
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.235
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021786 0 0 0 0 0 133 59 152 49 169 141 83
2021/2022617 21 39 30 26 50 51 41 40 33 73 64 149
2022/2023758 77 43 26 100 122 113 48 44 95 10 34 46
2023/2024359 59 46 12 11 10 49 21 30 7 19 10 85
2024/20251.772 42 25 136 70 240 134 96 107 297 164 260 201
2025/20262.697 471 236 434 610 685 261 0 0 0 0 0 0
Totale 11.520